|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| A61K 31/553 | |||
| C12Q 1/68 |
| (11) | Number of the document | 3314265 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16733928.2 |
| Date of filing the European patent application | 2016-06-28 | |
| (97) | Date of publication of the European application | 2018-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/064920 |
| Date | 2016-06-28 |
| (87) | Number | WO 2017/001362 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 201562186236 P | 2015-06-29 | US |
| (72) |
EDGAR, Kyle, US
FRIEDMAN, Lori, US
SAMPATH, Deepak, US
SONG, Kyung, US
WERTZ, Ingrid, US
WILSON, Timothy, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | METHODS OF TREATMENT WITH TASELISIB |
| METHODS OF TREATMENT WITH TASELISIB |